Pharmaceuticals Global Group of Eight (G8) Industry Guide 2020-2029
SummaryThe G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market size (value , and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The G8 countries contributed $9,23,903.9 million in 2024 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 4% between 2020 and 2024. The G8 countries are expected to reach a value of $11,50,034.3 million in 2029, with a CAGR of 4.5% over the 2024-29 period.
- Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $5,69,333.8 million in 2024. This was followed by Germany and Japan, with a value of $85,905.4 and $69,384.6 million, respectively.
- The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $7,09,520.1 million in 2016, followed by Germany and Japan with expected values of $1,07,651.0 and $82,456.9 million, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the G8 pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
Reasons To Buy
- What was the size of the G8 pharmaceuticals market by value in 2024?
- What will be the size of the G8 pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the G8 pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up the G8 pharmaceuticals market?
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.